Bracco SpA

For more than eighty years, Bracco has been working in life sciences to promote a deeper understanding, anticipate diagnosis, and offer prevention through leading edge solutions. To preserve the real wealth of today’s society, and promote what pushes forward the frontiers in research: human health.

Achieving this doesn’t just mean developing integrated imaging solutions for healthcare. Through our corporate and social responsibility initiatives, we are committed to safeguarding the environment, and to supporting the cultural arts.

Our greater goal is what we will achieve in the future. In healthcare, every frontier that has been overcome has been a starting point; a conquest that benefits everyone.

Bracco is an international Group active in the healthcare sector through Bracco Imaging (diagnostic imaging), Pharma (prescription and over the counter drugs), Acist Medical Systems (medical devices and advanced imaging agents injection systems based in Minneapolis, USA), and the Centro Diagnostico Italiano diagnostic clinic in Milan. It has more than 2,700 employees and annual total consolidated revenues of one billion Euro, of which 65% from international sales and it is present worldwide. In the Research and Development area, the company invests approximately 11% of reference turnover in the imaging diagnostics and medical devices sectors and has a portfolio comprising over 1,500 patents.

Diagnostic Imaging